Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population

ClinicalTrials.gov ID: NCT02661490

Public ClinicalTrials.gov record NCT02661490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 5:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-blind, Safety and Immunogenicity Trial of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in Healthy Elderly Adults

Study identification

NCT ID
NCT02661490
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Takeda
Industry
Enrollment
320 participants

Conditions and interventions

Conditions

Interventions

  • Norovirus GI.1/GII.4 Bivalent VLP Vaccine Biological
  • 0.9% sodium chloride (saline) Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2016
Primary completion
Oct 27, 2016
Completion
Sep 28, 2017
Last update posted
May 17, 2020

2016 – 2017

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Simon Williamson Clinic Birmingham Alabama 35211
Fountain Hills Family Practice, P.C. Fountain Hills Arizona 85268
Southwest Family Medicine Littleton Colorado 80127
Miami Research Associates Miami Florida 33143
Johnson County Clin-Trials Lenexa Kansas 66219
St. Louis University, School of Medicine St Louis Missouri 63104
Regional Clinical Research Inc. Endwell New York 13760
University of Rochester Rochester New York 14642
Cincinnati Childrens Hospital Medical Center Cincinnati Ohio 45229-3039
Group Health Research Institute Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02661490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2020 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02661490 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →